Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer

References

• Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632–634. doi:10.1111/j.1538-7836.2007.02374.x17319909
   PubMed Web of Science ®Google Scholar
• Ruiz-Artacho P, Trujillo-Santos J, Lopez-Jimenez L, et al. Clinical characteristics and outcomes of patients with lung cancer and venous thromboembolism. TH Open. 2018;2(2):e210–e217. doi:10.1055/s-0038-165654231249944
   PubMedGoogle Scholar
• Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404–1413.23146958
   PubMed Web of Science ®Google Scholar
• Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219–230.27882374
   PubMed Web of Science ®Google Scholar
• Blix K, Gran OV, Severinsen MT, et al. Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort. J Thromb Haemost. 2018;16(7):1327–1335.29691978
   PubMed Web of Science ®Google Scholar
• Zhang YH, Yang YH, Chen WH, et al. Prevalence and Associations of VTE in patients with newly diagnosed lung cancer. Chest. 2014;146(3):650–658.24676401
   PubMed Web of Science ®Google Scholar
• Zer A, Moskovitz M, Hwang DM, et al. ALK-Rearranged non-small-cell lung cancer is associated with a high rate of venous thromboembolism. Clin Lung Cancer. 2017;18(2):156–161.27913214
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Leiva O, Dagogo-Jack I, et al. Impact of ALK rearrangement on venous and arterial thrombotic risk in NSCLC. J Thorac Oncol. 2020;15(9):1497–1506.32437899
   PubMed Web of Science ®Google Scholar
• Dou FF, Li HQ, Zhu M, et al. Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer. Resp Res. 2018;19(1):88.
   PubMedGoogle Scholar
• Dou FF, Zhang Y, Yi JW, et al. Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: a prospective cohort study. Thromb Res. 2020;186:36–41. doi:10.1016/j.thromres.2019.12.00931864154
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Poniewierski MS, Culakova E, et al. Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK). Oncologist. 2018;23(2):247–255. doi:10.1634/theoncologist.2017-020528951500
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Arbour K, Riely G. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764–774. doi:10.1001/jama.2019.1105831454018
   PubMed Web of Science ®Google Scholar
• Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640–649. doi:10.1056/NEJMoa191662332786189
   PubMed Web of Science ®Google Scholar
• Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125(6):490–493. doi:10.1016/j.thromres.2009.12.02320097409
   PubMed Web of Science ®Google Scholar
• Kourelis TV, Wysokinska EM, Wang Y, Yang P, Mansfield AS, Tafur AJ. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer. Lung Cancer. 2014;86(3):358–362. doi:10.1016/j.lungcan.2014.10.00325453848
   PubMed Web of Science ®Google Scholar
• Giroux D, Van Schil P, Asamura H, et al. The IASLC lung cancer staging project: a renewed call to participation. J Thoracic Oncol. 2018;13(6):801–809. doi:10.1016/j.jtho.2018.02.012
   PubMed Web of Science ®Google Scholar
• Liu JJ, Wang P, Yan Y, Song K. Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis. Sci Rep-Uk. 2020;10(1).
   Web of Science ®Google Scholar
• Wang Z, Yan HH, Yang JJ, et al. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients. Support Care Cancer. 2015;23(3):635–641. doi:10.1007/s00520-014-2405-y25155313
   PubMed Web of Science ®Google Scholar
• Vergati M, Della-Morte D, Ferroni P, et al. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer. Rejuvenation Res. 2013;16(3):224–231. doi:10.1089/rej.2013.140923521603
   PubMed Web of Science ®Google Scholar
• Ng TL, Smith DE, Mushtaq R, et al. ROS1 gene rearrangements are associated with an elevated risk of peridiagnosis thromboembolic events. J Thorac Oncol. 2019;14(4):596–605. doi:10.1016/j.jtho.2018.12.00130543838
   PubMed Web of Science ®Google Scholar
• Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2005;105(4):1734–1741.15494427
   PubMed Web of Science ®Google Scholar
• Parkin L, Sweetland S, Balkwill A, Green J, Reeves G, Beral V. Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation. 2012;125(15):1897–1904.22394567
   PubMed Web of Science ®Google Scholar
• Lee YG, Kim I, Lee E, et al. Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer. Thromb Haemost. 2014;111(6):1112–1120.24477503
   PubMed Web of Science ®Google Scholar
• Chen JS, Hung CY, Chang H, et al. Venous thromboembolism in asian patients with pancreatic cancer following palliative chemotherapy: low incidence but a negative prognosticator for those with early onset. Cancers (Basel). 2018;10(12):501.
   PubMed Web of Science ®Google Scholar
• Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist. 2007;12(2):231–242.17296819
   PubMed Web of Science ®Google Scholar
• Henry DH, Dahl NV, Auerbach MA. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron. Am J Hematol. 2012;87(3):308–310.22262486
   PubMed Web of Science ®Google Scholar
• Hicks LK, Cheung MC, Ding K, et al. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer. 2009;115(23):5516–5525.19711465
   PubMed Web of Science ®Google Scholar
• Mego M, Karaba M, Minarik G, et al. Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patients. Breast J. 2015;21(2):155–160.25623304
   PubMed Web of Science ®Google Scholar
• Mandoj C, Tomao L, Conti L. Coagulation in brain tumors: biological basis and clinical implications. Front Neurol. 2019;10:181.30949114
   PubMed Web of Science ®Google Scholar